NeuroDerm's P2P Acquisition

NeuroDerm raised a round of funding on October 18, 2017. Investors include Mitsubishi Tanabe Pharma.

NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhan…

Articles about NeuroDerm's P2P Acquisition: